Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Irving

Showing results (251-260 of 321) with videos related to

Pageof 33
Sort By:
BJOG : an International Journal of Obstetrics and Gynaecology|October 12, 2000
Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological studyW L Irving, D K James, T Stephenson, et al.
European Radiology|December 4, 2018
Short-term changes observed in multiparametric liver MRI following therapy with direct-acting antivirals in chronic hepatitis C virus patientsC Bradley, R A Scott, E Cox, et al.
Hepatology (Baltimore, Md.)|February 12, 2016
Is increased hepatitis C virus case-finding combined with current or 8-week to 12-week direct-acting antiviral therapy cost-effective in UK prisons? A prevention benefit analysisNatasha K Martin, Peter Vickerman, Iain F Brew, et al.
Antiviral Research|July 25, 2014
Development of a high-throughput pyrosequencing assay for monitoring temporal evolution and resistance associated variant emergence in the Hepatitis C virus protease coding-regionWilliam L Irving, Daniel Rupp, C Patrick McClure, et al.
Journal of Medical Virology|November 26, 1998
GBV-C/HGV coinfection in HIV-1-positive men: frequent detection of viral RNA in blood plasma but absence from seminal fluid plasmaR C Hollingsworth, C L Jameson, J E Minton, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2002
Effect of combination therapy (ribavirin and interferon) in HCV-related glomerulopathyAlaa A Sabry, Mohamed A Sobh, Hussein A Sheaashaa, et al.
The Journal of Hospital Infection|September 25, 2021
Effectiveness of portable air filtration on reducing indoor aerosol transmission: preclinical observational trialsJ H Lee, M Rounds, F McGain, et al.
Journal of Virology|December 25, 2015
A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization ResistanceRichard A Urbanowicz, C Patrick McClure, Richard J P Brown, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 8, 2025
Use of polyethylene glycol precipitation and ultracentrifugation to enhance the sensitivity of hepatitis B virus DNA detectionMichael X Fu, Osmany Larralde, Richard Mayne, et al.
Influenza and Other Respiratory Viruses|June 8, 2022
Human parainfluenza 2 & 4: Clinical and genetic epidemiology in the UK, 2013-2017, reveals distinct disease features and co-circulating genomic subtypesAkhil Chellapuri, Matthew Smitheman, Joseph G Chappell, et al.
Pageof 33

Showing results (251-260 of 321) with videos related to

Sort By:
Pageof 33
BJOG : an International Journal of Obstetrics and Gynaecology|October 12, 2000
Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological studyW L Irving, D K James, T Stephenson, et al.
European Radiology|December 4, 2018
Short-term changes observed in multiparametric liver MRI following therapy with direct-acting antivirals in chronic hepatitis C virus patientsC Bradley, R A Scott, E Cox, et al.
Hepatology (Baltimore, Md.)|February 12, 2016
Is increased hepatitis C virus case-finding combined with current or 8-week to 12-week direct-acting antiviral therapy cost-effective in UK prisons? A prevention benefit analysisNatasha K Martin, Peter Vickerman, Iain F Brew, et al.
Antiviral Research|July 25, 2014
Development of a high-throughput pyrosequencing assay for monitoring temporal evolution and resistance associated variant emergence in the Hepatitis C virus protease coding-regionWilliam L Irving, Daniel Rupp, C Patrick McClure, et al.
Journal of Medical Virology|November 26, 1998
GBV-C/HGV coinfection in HIV-1-positive men: frequent detection of viral RNA in blood plasma but absence from seminal fluid plasmaR C Hollingsworth, C L Jameson, J E Minton, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2002
Effect of combination therapy (ribavirin and interferon) in HCV-related glomerulopathyAlaa A Sabry, Mohamed A Sobh, Hussein A Sheaashaa, et al.
The Journal of Hospital Infection|September 25, 2021
Effectiveness of portable air filtration on reducing indoor aerosol transmission: preclinical observational trialsJ H Lee, M Rounds, F McGain, et al.
Journal of Virology|December 25, 2015
A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization ResistanceRichard A Urbanowicz, C Patrick McClure, Richard J P Brown, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 8, 2025
Use of polyethylene glycol precipitation and ultracentrifugation to enhance the sensitivity of hepatitis B virus DNA detectionMichael X Fu, Osmany Larralde, Richard Mayne, et al.
Influenza and Other Respiratory Viruses|June 8, 2022
Human parainfluenza 2 & 4: Clinical and genetic epidemiology in the UK, 2013-2017, reveals distinct disease features and co-circulating genomic subtypesAkhil Chellapuri, Matthew Smitheman, Joseph G Chappell, et al.
Pageof 33